Kim Youlim, Lee Hyun, Chung Sung Jun, Yeo Yoomi, Park Tai Sun, Park Dong Won, Min Kyung Hoon, Kim Sang-Heon, Kim Tae-Hyung, Sohn Jang Won, Moon Ji-Yong, Yoon Ho Joo
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University Hospital, School of Medicine, Konkuk University, Seoul, Korea.
Department of Internal Medicine, College of Medicine, Hanyang University, Seoul, Korea.
J Asthma Allergy. 2021 Oct 28;14:1267-1275. doi: 10.2147/JAA.S318502. eCollection 2021.
Despite the usefulness of airway hyperresponsiveness (AHR) testing in diagnosing and monitoring asthma, it is challenging to perform in a real-world setting. Forced expiratory flow between 25% and 75% of vital capacity (FEF), a pulmonary measurement that can be obtained easily during routine spirometry, represents the status of medium-sized and small airways. However, the performance of FEF in predicting AHR has not been well elucidated. Therefore, we investigated whether FEF can predict AHR to mannitol.
We performed a retrospective cohort study of 428 patients who visited a single clinic due to cough, wheezing, or dyspnea. All patients underwent spirometry with a mannitol provocation test. We compared the area under the curve (AUC) of the percentage of the predicted values of FEF (FEF %pred) with that of forced expiratory volume in 1 second (FEV%pred), FEV/forced vital capacity (FVC), and FEF/ FVC for predicting AHR.
The rate of AHR to mannitol was 20.3%. In the overall study population, the AUC of FEF %pred for predicting AHR (0.772; 95% confidence interval [CI], 0.729-0.811) was significantly higher than that of FEV%pred (0.666; 95% CI, 0.619-0.710; p < 0.001), FEV/FVC (0.741; 95% CI, 0.697-0.782; p = 0.047), and FEF/FVC (0.741, 95% CI = 0.696-0.782, p = 0.046). The sensitivity, specificity, positive predictive value, and negative predictive value of FEF %pred <81% for predicting AHR in the overall study population were 77.0% (95% CI = 66.8-85.4%), 63.9% (95% CI = 58.6-69.0), 35.3%, and 91.6%, respectively. When we restricted the study group to subjects with normal lung function, the results were similar.
Our results indicate that FEF %pred can be used as a surrogate for predicting AHR in patients with respiratory symptoms.
尽管气道高反应性(AHR)检测在哮喘的诊断和监测中具有重要作用,但在实际临床环境中进行检测仍具有挑战性。用力肺活量25%至75%之间的呼气流量(FEF)是一种在常规肺功能检查中易于获得的肺部测量指标,代表中小气道的状态。然而,FEF在预测AHR方面的性能尚未得到充分阐明。因此,我们研究了FEF是否能够预测对甘露醇的AHR。
我们对428例因咳嗽、喘息或呼吸困难前往单一诊所就诊的患者进行了一项回顾性队列研究。所有患者均接受了肺功能检查及甘露醇激发试验。我们比较了FEF预测值百分比(FEF %pred)、第1秒用力呼气容积预测值百分比(FEV%pred)、FEV/用力肺活量(FVC)以及FEF/FVC预测AHR的曲线下面积(AUC)。
对甘露醇的AHR发生率为20.3%。在整个研究人群中,FEF %pred预测AHR的AUC(0.772;95%置信区间[CI],0.729 - 0.811)显著高于FEV%pred(0.666;95% CI,0.619 - 0.710;p < 0.001)、FEV/FVC(0.741;95% CI,0.697 - 0.782;p = 0.047)以及FEF/FVC(0.741,95% CI = 0.696 - 0.782,p = 0.046)。在整个研究人群中,FEF %pred <81%预测AHR的敏感性、特异性、阳性预测值和阴性预测值分别为77.0%(95% CI = 66.8 - 85.4%)、63.9%(95% CI = 58.6 - 69.0)、35.3%和91.6%。当我们将研究组限制为肺功能正常的受试者时,结果相似。
我们的结果表明,FEF %pred可作为预测有呼吸道症状患者AHR的替代指标。